| 1 |
32401663 |
10.1080/15513815.2020.1764680 |
2022 |
PD-L1 and PD-L2 Mutations in Pediatric Hodgkin Lymphoma: Do They Have Any Prognostic Significance? |
CD274 |
| 2 |
34520052 |
10.1111/bjh.17793 |
2022 |
9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trial. |
CD274 |
| 3 |
34842351 |
10.1002/cam4.4462 |
2022 |
PD-L1 expression is associated with the spontaneous regression of patients with methotrexate-associated lymphoproliferative disorders. |
CD274 |
| 4 |
34862664 |
10.1111/apm.13195 |
2022 |
Prognostic implications of the tumor immune microenvironment and immune checkpoint pathway in primary central nervous system diffuse large B-cell lymphoma in the North Indian population. |
CD274 |
| 5 |
34959071 |
10.1016/j.molimm.2021.12.014 |
2022 |
HomA and HomB, outer membrane proteins of Helicobacter pylori down-regulate activation-induced cytidine deaminase (AID) and Ig switch germline transcription and thereby affect class switch recombination (CSR) of Ig genes in human B-cells. |
CD274 |
| 6 |
34996890 |
10.1038/s41598-021-02515-5 |
2022 |
The expression and clinical significance of programmed cell death receptor 1 and its ligand in tumor tissues of patients with extranodal nasal NK/T cell lymphoma. |
CD274 |
| 7 |
35032188 |
10.1007/s00277-022-04760-8 |
2022 |
Prognostic implication of CTLA-4, PD-1, and PD-L1 expression in aggressive adult T-cell leukemia-lymphoma. |
CD274 |
| 8 |
35165282 |
10.1038/s41467-022-28479-2 |
2022 |
EBV miRNAs BART11 and BART17-3p promote immune escape through the enhancer-mediated transcription of PD-L1. |
CD274 |
| 9 |
35194801 |
10.1111/bjd.21063 |
2022 |
Expression of immune checkpoint molecules programmed death protein 1, programmed death-ligand 1 and inducible T-cell co-stimulator in mycosis fungoides and Sézary syndrome: association with disease stage and clinical outcome. |
CD274 |
| 10 |
35344582 |
10.1182/blood.2021014007 |
2022 |
Extracellular vesicles and PD-L1 suppress macrophages, inducing therapy resistance in TP53-deficient B-cell malignancies. |
CD274 |
| 11 |
35359004 |
10.1182/bloodadvances.2022007104 |
2022 |
SIRPα+ macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximab. |
CD274 |
| 12 |
35417939 |
10.3324/haematol.2021.280352 |
2022 |
Genomic determinants impacting the clinical outcome of mogamulizumab treatment for adult T-cell leukemia/lymphoma. |
CD274 |
| 13 |
35655072 |
10.1038/s41598-022-13101-8 |
2022 |
Plasma extracellular vesicles bearing PD-L1, CD40, CD40L or TNF-RII are significantly reduced after treatment of AIDS-NHL. |
CD274 |
| 14 |
35680804 |
10.19746/j.cnki.issn.1009-2137.2022.03.018 |
2022 |
[Inhibitory Effect of Interference with PD-L1 Expression on B-cell lymphoma in Mice]. |
CD274 |
| 15 |
35741318 |
10.3390/diagnostics12061507 |
2022 |
Hodgkin Lymphoma: Biology and Differential Diagnostic Problem. |
CD274 |
| 16 |
35764886 |
10.1038/s41598-022-15162-1 |
2022 |
Mutations in the miR-142 gene are not common in myeloproliferative neoplasms. |
CD274 |
| 17 |
35767735 |
10.1182/bloodadvances.2022007046 |
2022 |
The identification of TCF1+ progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockade. |
CD274 |
| 18 |
35774848 |
10.1155/2022/3276925 |
2022 |
Identification of CXCR4 Upregulation in Diffuse Large B-Cell Lymphoma Associated with Prognostic Significance and Clinicopathological Characteristics. |
CD274 |
| 19 |
35789115 |
10.1111/his.14718 |
2022 |
Hodgkinoid histiocytosis: an atypical nodal CD30 and S100-positive histiocytosis with eosinophilia. |
CD274 |
| 20 |
35848760 |
10.1097/PAS.0000000000001899 |
2022 |
9p24.1 Genetic Alteration and PD-L1 Expression Are Characteristic of De Novo and Methotrexate-associated Epstein-Barr Virus-positive Hodgkin Lymphoma, But Not Methotrexate-associated Hodgkin-like Lesions. |
CD274 |
| 21 |
35922773 |
10.1186/s12885-022-09803-x |
2022 |
Expression of PD1 and PDL1 as immune-checkpoint inhibitors in mantle cell lymphoma. |
CD274 |
| 22 |
32803453 |
10.1007/s00428-020-02901-w |
2021 |
Clinicopathological analysis of neoplastic PD-L1-positive EBV<sup>+</sup> diffuse large B cell lymphoma, not otherwise specified, in a Japanese cohort. |
CD274 |
| 23 |
32871584 |
10.1182/blood.2020006464 |
2021 |
Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma. |
CD274 |
| 24 |
32964767 |
10.1080/10428194.2020.1821011 |
2021 |
Frequent mutations in HLA and related genes in extranodal NK/T cell lymphomas. |
CD274 |
| 25 |
33028589 |
10.1158/1078-0432.CCR-20-1457 |
2021 |
CD19-specific CAR T Cells that Express a PD-1/CD28 Chimeric Switch-Receptor are Effective in Patients with PD-L1-positive B-Cell Lymphoma. |
CD274 |
| 26 |
33091534 |
10.1016/j.canlet.2020.10.024 |
2021 |
NLRP3 inflammasome upregulates PD-L1 expression and contributes to immune suppression in lymphoma. |
CD274 |
| 27 |
33184699 |
10.1007/s00262-020-02787-2 |
2021 |
Epstein-Barr virus recruits PDL1-positive cells at the microenvironment in pediatric Hodgkin lymphoma. |
CD274 |
| 28 |
33232972 |
10.1182/blood.2020005244 |
2021 |
Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomas. |
CD274 |
| 29 |
33247999 |
10.1111/cas.14752 |
2021 |
Interleukin 6 regulates the expression of programmed cell death ligand 1 in thyroid cancer. |
CD274 |
| 30 |
33277223 |
10.1016/j.clml.2020.11.009 |
2021 |
Expression of the Immune Checkpoint Regulators LAG-3 and TIM-3 in Classical Hodgkin Lymphoma. |
CD274 |
| 31 |
33299141 |
10.1038/s41375-020-01105-0 |
2021 |
Regulation of PD-L1 expression is a novel facet of cyclic-AMP-mediated immunosuppression. |
CD274 |
| 32 |
33369766 |
10.1002/hon.2836 |
2021 |
Pembrolizumab for refractory primary mediastinal B-cell lymphoma with central nervous system involvement. |
CD274 |
| 33 |
33389078 |
10.1007/s00432-020-03446-w |
2021 |
Vincristine upregulates PD-L1 and increases the efficacy of PD-L1 blockade therapy in diffuse large B-cell lymphoma. |
CD274 |
| 34 |
33480087 |
10.1002/hon.2839 |
2021 |
High-grade B-cell lymphomas with MYC and BCL2 translocations lack tumor-associated macrophages and PD-L1 expression: A possible noninflamed subgroup. |
CD274 |
| 35 |
33512416 |
10.1182/blood.2020007245 |
2021 |
Frequent genetic alterations in immune checkpoint-related genes in intravascular large B-cell lymphoma. |
CD274 |
| 36 |
33517324 |
10.2967/jnumed.120.258384 |
2021 |
Synthesis and Preclinical Evaluation of a <sup>68</sup>Ga-Labeled Adnectin, <sup>68</sup>Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression. |
CD274 |
| 37 |
33558066 |
10.1016/j.pathol.2020.11.004 |
2021 |
CD68-positive tumour associated macrophages, PD-L1 expression, and EBV latent infection in a high HIV-prevalent South African cohort of Hodgkin lymphoma patients. |
CD274 |
| 38 |
33590326 |
10.1007/s00595-021-02236-2 |
2021 |
Immunotherapeutic advances in gastric cancer. |
CD274 |
| 39 |
33620088 |
10.1111/bjh.17362 |
2021 |
Soluble PD-L1 is a promising disease biomarker but does not reflect tissue expression in classic Hodgkin lymphoma. |
CD274 |
| 40 |
33674274 |
10.1158/1078-0432.CCR-21-0133 |
2021 |
Efficacy of Decitabine plus Anti-PD-1 Camrelizumab in Patients with Hodgkin Lymphoma Who Progressed or Relapsed after PD-1 Blockade Monotherapy. |
CD274 |
| 41 |
33686666 |
10.1111/bjh.17366 |
2021 |
Infiltration of CD163-, PD-L1- and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors. |
CD274 |
| 42 |
33691262 |
10.1016/j.ejca.2021.01.020 |
2021 |
Dose escalation and expansion (phase Ia/Ib) study of GLS-010, a recombinant fully human antiprogrammed death-1 monoclonal antibody for advanced solid tumors or lymphoma. |
CD274 |
| 43 |
33721375 |
10.1111/ejh.13621 |
2021 |
Soluble programmed cell death protein 1 (sPD-1) and the soluble programmed cell death ligands 1 and 2 (sPD-L1 and sPD-L2) in lymphoid malignancies. |
CD274 |
| 44 |
33764958 |
10.12659/MSM.929431 |
2021 |
Knockdown of Chitinase 3-Like-1 Inhibits Cell Proliferation, Promotes Apoptosis, and Enhances Effect of Anti-Programmed Death Ligand 1 (PD-L1) in Diffuse Large B Cell Lymphoma Cells. |
CD274 |
| 45 |
33807678 |
10.3390/jof7030186 |
2021 |
Invasive Fungal Diseases in Children with Hematological Malignancies Treated with Therapies That Target Cell Surface Antigens: Monoclonal Antibodies, Immune Checkpoint Inhibitors and CAR T-Cell Therapies. |
CD274 |
| 46 |
33889438 |
10.1080/2162402X.2021.1907059 |
2021 |
VISTA and PD-L1 synergistically predict poor prognosis in patients with extranodal natural killer/T-cell lymphoma. |
CD274 |
| 47 |
33918793 |
10.3390/cancers13081801 |
2021 |
Clinical Applications of Genomic Alterations in ATLL: Predictive Markers and Therapeutic Targets. |
CD274 |
| 48 |
33941556 |
NA |
2021 |
PD1/PD-L1 Expressions in Plasmablastic Lymphoma with Clinicopathological Correlation. |
CD274 |
| 49 |
33972504 |
10.1038/s41408-021-00477-5 |
2021 |
Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome. |
CD274 |
| 50 |
34021249 |
10.1038/s41375-021-01289-z |
2021 |
Thyroid MALT lymphoma: self-harm to gain potential T-cell help. |
CD274 |
| 51 |
34077007 |
NA |
2021 |
Clinical significance of PD-1 and PD-L1 molecules in patients with diffuse large B-cell lymphoma, not otherwise specified: Correlation with clinical and pathological findings. |
CD274 |
| 52 |
34078046 |
10.3760/cma.j.cn112151-20201223-00953 |
2021 |
[Genetic abnormality and protein expression of C-MYC and PD-L1 in ALK-negative anaplastic large cell lymphoma]. |
CD274 |
| 53 |
34130989 |
10.1136/jitc-2021-002558 |
2021 |
Pan-cancer analysis of <i>CD274</i> (PD-L1) mutations in 314,631 patient samples and subset correlation with PD-L1 protein expression. |
CD274 |
| 54 |
34153661 |
10.1016/j.intimp.2021.107870 |
2021 |
PD-1 and PD-L1 inhibitors foster the progression of adult T-cell Leukemia/Lymphoma. |
CD274 |
| 55 |
34181355 |
10.31557/APJCP.2021.22.6.1943 |
2021 |
NFATc1 is Suppressed in Tumor Microenvironment of Hodgkin Lymphoma. |
CD274 |
| 56 |
34327781 |
10.1111/cas.15091 |
2021 |
Current progress and future perspectives of research on intravascular large B-cell lymphoma. |
CD274 |
| 57 |
34363798 |
10.1016/j.humpath.2021.07.011 |
2021 |
Clinicopathological features and prognostic significance of programmed death ligand 1 in pediatric ALK-positive anaplastic large cell lymphoma: results of the ALCL99 treatment in Japan. |
CD274 |
| 58 |
34405609 |
10.3760/cma.j.cn112151-20210110-00023 |
2021 |
[Characteristics of PD-L1 expression in tumor cells and tumor microenvironment of DLBCL with MYD88 L265P mutation]. |
CD274 |
| 59 |
34534136 |
10.1097/PAS.0000000000001809 |
2021 |
Clinicopathologic Analysis of Primary Adrenal Diffuse Large B-Cell Lymphoma: A Reappraisal of 23 Japanese Patients Based on EBV Association and PD-L1 Expression in Tumor Cells. |
CD274 |
| 60 |
34543472 |
10.1002/hon.2926 |
2021 |
Combined tumor-associated macrophages biomarker predicting extremely poor outcome of patients with primary central nervous system lymphoma. |
CD274 |
| 61 |
34584457 |
10.2147/CMAR.S317319 |
2021 |
Myelin and Lymphocyte Protein (MAL): A Novel Biomarker for Uterine Corpus Endometrial Carcinoma. |
CD274 |
| 62 |
34615710 |
10.1073/pnas.2105822118 |
2021 |
Single-cell profiling reveals the importance of CXCL13/CXCR5 axis biology in lymphocyte-rich classic Hodgkin lymphoma. |
CD274 |
| 63 |
34649362 |
10.1016/j.biopha.2021.112238 |
2021 |
An evidence mapping and scientometric analysis of the top-100 most cited clinical trials of anti-PD-1/PD-L1 drugs to treat cancers. |
CD274 |
| 64 |
34661162 |
10.1158/2643-3230.BCD-21-0044 |
2021 |
Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1. |
CD274 |
| 65 |
34742294 |
10.1186/s13000-021-01163-7 |
2021 |
Large cell morphology, CMYC+ tumour cells, and PD-1+ tumour cell/intense PD-L1+ cell reactions are important prognostic factors in nodal peripheral T-cell lymphomas with T follicular helper markers. |
CD274 |
| 66 |
34955650 |
10.2147/IJGM.S341557 |
2021 |
Combined Identification of Novel Markers for Diagnosis and Prognostic of Classic Hodgkin Lymphoma. |
CD274 |
| 67 |
31163235 |
10.1016/j.jaad.2019.05.077 |
2020 |
Programmed cell death 1 protein and programmed death-ligand 1 inhibitors in the treatment of nonmelanoma skin cancer: A systematic review. |
CD274 |
| 68 |
31330525 |
10.1159/000500974 |
2020 |
Programmed Cell Death 1 and Programmed Cell Death Ligands in Extranodal Natural Killer/T Cell Lymphoma: Expression Pattern and Potential Prognostic Relevance. |
CD274 |
| 69 |
31383967 |
10.1038/s41379-019-0336-3 |
2020 |
PD-L1 expression is associated with ALK positivity and STAT3 activation, but not outcome in patients with systemic anaplastic large cell lymphoma. |
CD274 |
| 70 |
31493237 |
10.1007/s00535-019-01616-3 |
2020 |
Prognostic impact of PD-L1 expression in primary gastric and intestinal diffuse large B-cell lymphoma. |
CD274 |
| 71 |
31653980 |
10.1038/s41379-019-0392-8 |
2020 |
Immune subtyping of extranodal NK/T-cell lymphoma: a new biomarker and an immune shift during disease progression. |
CD274 |
| 72 |
31699300 |
10.1016/j.pathol.2019.09.005 |
2020 |
Hodgkin lymphoma: a review of pathological features and recent advances in pathogenesis. |
CD274 |
| 73 |
31709594 |
10.1002/cbf.3463 |
2020 |
Epigenetic abnormalities of classical Hodgkin lymphoma and its effect on immune escape. |
CD274 |
| 74 |
31752573 |
10.1080/10428194.2019.1691200 |
2020 |
New murine models of aggressive lymphoma. |
CD274 |
| 75 |
31787352 |
10.1016/j.imbio.2019.11.007 |
2020 |
Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphoma. |
CD274 |
| 76 |
31790142 |
10.1182/blood.2019000847 |
2020 |
The immune landscape and response to immune checkpoint blockade therapy in lymphoma. |
CD274 |
| 77 |
31811434 |
10.1007/s00428-019-02695-6 |
2020 |
Characterisation of tumour microenvironment and immune checkpoints in primary central nervous system diffuse large B cell lymphomas. |
CD274 |
| 78 |
31812554 |
10.1016/S1470-2045(19)30671-0 |
2020 |
Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial. |
CD274 |
| 79 |
31825135 |
10.1002/1878-0261.12616 |
2020 |
High CD206 levels in Hodgkin lymphoma-educated macrophages are linked to matrix-remodeling and lymphoma dissemination. |
CD274 |
| 80 |
31829043 |
10.2217/fon-2019-0468 |
2020 |
Atezolizumab for use in PD-L1-positive unresectable, locally advanced or metastatic triple-negative breast cancer. |
CD274 |
| 81 |
31879046 |
10.1016/j.prp.2019.152703 |
2020 |
TLR9 expression is associated with PD-L1 expression and indicates a poor prognosis in patients with peripheral T-cell lymphomas. |
CD274 |
| 82 |
31894883 |
10.1111/pin.12891 |
2020 |
Diagnostic utility of programmed cell death ligand 1 (clone SP142) in mediastinal composite lymphoma: A report of two cases. |
CD274 |
| 83 |
31894892 |
10.1111/pin.12888 |
2020 |
Syncytial variant of classic Hodgkin lymphoma: Four cases diagnosed with the aid of CD274/programmed cell death ligand 1 immunohistochemistry. |
CD274 |
| 84 |
31903640 |
10.1002/jcla.23173 |
2020 |
Adrenal diffuse large B-cell lymphoma with high PD-L1 expression: Two case reports and literature review. |
CD274 |
| 85 |
31911188 |
10.1016/j.semcancer.2020.01.001 |
2020 |
Exposing Hidden Targets: Combining epigenetic and immunotherapy to overcome cancer resistance. |
CD274 |
| 86 |
31911474 |
10.1073/pnas.1908158117 |
2020 |
High-dose ascorbic acid synergizes with anti-PD1 in a lymphoma mouse model. |
CD274 |
| 87 |
31977037 |
10.1093/ajcp/aqz198 |
2020 |
Immunohistochemical Assessment of the Diagnostic Utility of PD-L1 (Clone SP142) for Methotrexate-Associated Lymphoproliferative Disorders With an Emphasis of Neoplastic PD-L1 (Clone SP142)-Positive Classic Hodgkin Lymphoma Type. |
CD274 |
| 88 |
31983543 |
10.1016/j.beem.2019.101370 |
2020 |
New insight in endocrine-related adverse events associated to immune checkpoint blockade. |
CD274 |
| 89 |
31992262 |
10.1186/s12885-020-6550-z |
2020 |
Prognostic value and clinicopathological characteristics of PD-L1 overexpression in non-Hodgkin lymphoma: a meta-analysis. |
CD274 |
| 90 |
32030732 |
10.1111/bjh.16494 |
2020 |
Pembrolizumab with R-CHOP in previously untreated diffuse large B-cell lymphoma: potential for biomarker driven therapy. |
CD274 |
| 91 |
32054467 |
10.1186/s12885-020-6612-2 |
2020 |
Serum levels of soluble programmed death-ligand 1 (sPD-L1) in patients with primary central nervous system diffuse large B-cell lymphoma. |
CD274 |
| 92 |
32066566 |
10.1158/0008-5472.CAN-19-2948 |
2020 |
Revisiting Immunotherapy: A Focus on Prostate Cancer. |
CD274 |
| 93 |
32089543 |
10.1038/s41375-020-0737-9 |
2020 |
PD-L1/L2 protein levels rapidly increase on monocytes via trogocytosis from tumor cells in classical Hodgkin lymphoma. |
CD274 |
| 94 |
32116068 |
10.1080/17474086.2020.1733405 |
2020 |
Identifying and treating candidates for checkpoint inhibitor therapies in multiple myeloma and lymphoma. |
CD274 |
| 95 |
32143684 |
10.1186/s13104-020-04975-w |
2020 |
Immunophenotyping of the PD-L1-positive cells in angioimmunoblastic T cell lymphoma and Hodgkin disease. |
CD274 |
| 96 |
32157792 |
10.1002/1878-0261.12664 |
2020 |
Overexpression of GLT1D1 induces immunosuppression through glycosylation of PD-L1 and predicts poor prognosis in B-cell lymphoma. |
CD274 |
| 97 |
32170448 |
10.1007/s00428-020-02790-z |
2020 |
Clinicopathological features of programmed cell death-1 and programmed cell death-ligand-1 expression in the tumor cells and tumor microenvironment of angioimmunoblastic T cell lymphoma and peripheral T cell lymphoma not otherwise specified. |
CD274 |
| 98 |
32248797 |
10.1186/s12885-020-06755-y |
2020 |
PD-L1 and PD-L2 expression in the tumor microenvironment including peritumoral tissue in primary central nervous system lymphoma. |
CD274 |
| 99 |
32295735 |
10.1016/j.clml.2019.11.021 |
2020 |
The Triple Positivity for EBV, PD-1, and PD-L1 Identifies a Very High Risk Classical Hodgkin Lymphoma. |
CD274 |
| 100 |
32366559 |
NA |
2020 |
Plasmablastic Lymphomas: Characterization of Tumor Microenvironment Using CD163 and PD-1 Immunohistochemistry. |
CD274 |
Datasets
Models
